Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sarepta Therapeutics Inc (NASDAQ:SRPT)

32.49
Delayed Data
As of May 24
 +0.22 / +0.68%
Today’s Change
14.83
Today|||52-Week Range
63.73
+18.45%
Year-to-Date
Big Fund Managers Offer Up Stock Pick Ideas
May 18 / TheStreet.com - Paid Partner Content
Paul Tudor Jones' Top 4 Health Care Buys
May 18 / GuruFocus News - Paid Partner Content

Today’s Trading

Previous close32.27
Today’s open32.33
Day’s range31.50 - 33.40
Volume2,260,887
Average volume (3 months)2,196,829
Market cap$1.8B
Dividend yield--
Data as of 05/24/2017

Growth & Valuation

Earnings growth (last year)-5.58%
Earnings growth (this year)+86.42%
Earnings growth (next 5 years)+0.37%
Revenue growth (last year)+332.64%
P/E ratioNM
Price/Sales246.40
Price/Book5.25

Competitors

 Today’s
change
Today’s
% change
TBPHTheravance Biopharma...+0.36+0.99%
PCRXPacira Pharmaceutica...-0.90-1.91%
PRTAProthena Corporation...+0.54+0.97%
HZNPHorizon Pharma PLC-0.05-0.49%
Data as of 05/24/2017

Financials

Next reporting dateAugust 10, 2017
EPS forecast (this quarter)-$0.90
Annual revenue (last year)$5.4M
Annual profit (last year)-$267.3M
Net profit margin-4,930.18%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Director
Edward M. Kaye
Executive VP, Chief Financial &
Business Officer
Sandesh Mahatme
Corporate headquarters
Cambridge, Massachusetts

Forecasts